GBM patients with CNP subtype may have less aggressive subtype of cancer

[News]

A diagnosis of glioblastoma multiforme (GBM) is generally a death sentence, but new research from the University of Wisconsin-Madison lab of Dr. John Kuo shows that at least one subtype is associated with a longer life expectancy. This discovery could help with better patient prognoses and lead to targeted drug treatments for GBM subtypes.

More... (http://www.news-medical.net/news/20120621/GBM-patients-with-CNP-subtype-may-have-less-aggressive-subtype-of-cancer.aspx)